When should low‑molecular‑weight heparin (e.g., enoxaparin) or unfractionated heparin be discontinued before a scheduled cesarean delivery?

When to Stop Heparin Before Cesarean Section in Antiphospholipid Syndrome

For scheduled cesarean delivery, discontinue prophylactic-dose LMWH (e.g., enoxaparin 40 mg daily) at least 12-24 hours before surgery, and stop unfractionated heparin at least 4-6 hours prior to the procedure.

Timing Based on Heparin Type and Dose

Low-Molecular-Weight Heparin (LMWH)

Prophylactic doses (e.g., enoxaparin 40 mg once daily):

• Stop 12-24 hours before scheduled cesarean delivery 1
• This timing balances thrombosis prevention with bleeding risk
• Research demonstrates this interval is safe with no increased hemorrhagic complications 1

Intermediate doses (e.g., enoxaparin 40 mg every 12 hours):

• Stop 24 hours before scheduled surgery 2
• Longer clearance time needed due to higher cumulative anticoagulant effect

Therapeutic doses (e.g., enoxaparin 1 mg/kg twice daily):

• Stop 24 hours before scheduled cesarean 3, 4
• Higher doses require extended clearance to minimize bleeding risk

Unfractionated Heparin (UFH)

Prophylactic doses (5,000-10,000 units subcutaneously every 12 hours):

• Stop 4-6 hours before surgery 2
• UFH has a much shorter half-life (60-90 minutes) compared to LMWH 2
• Can be restarted as early as 1 hour after neuraxial catheter removal 2

Critical Timing Considerations for Neuraxial Anesthesia

If neuraxial anesthesia (epidural/spinal) is planned, additional safety intervals apply:

For prophylactic LMWH:

• Must be at least 12 hours since last dose before neuraxial block placement 2
• Can restart 4 hours after catheter removal 2

For intermediate/therapeutic LMWH:

• Must be at least 24 hours since last dose before neuraxial block 2
• Can restart 4 hours after catheter removal 2

For UFH:

• Can place block 4-6 hours after last dose
• Can restart 1 hour after catheter removal 2

Special Circumstances and Pitfalls

If Spontaneous Labor Occurs

When labor begins unexpectedly while on anticoagulation:

• LMWH: If last dose was >12 hours ago, neuraxial anesthesia is generally safe 1
• LMWH: If last dose was <12 hours ago, avoid neuraxial block or wait until adequate clearance
• Consider checking anti-Xa levels if timing is uncertain and neuraxial anesthesia is desired

Wound Hematoma Risk

Critical warning: Administering LMWH within 2 hours of cesarean section significantly increases wound hematoma risk (12% vs 3%, OR 5.3) 5. This reinforces the importance of the 12-24 hour discontinuation window.

Restarting Anticoagulation Postpartum

For patients with APS requiring ongoing thromboprophylaxis:

With neuraxial anesthesia:

• Prophylactic LMWH: restart 4 hours after catheter removal, but not <12 hours after block placement 2
• UFH: restart 1 hour after catheter removal 2

Without neuraxial anesthesia:

• Can restart 8-12 hours postpartum if hemostasis is adequate 4
• Individualize timing if significant intraoperative bleeding occurred 2

Algorithm for Decision-Making

1. Determine heparin type and dose (prophylactic vs therapeutic)
2. Confirm cesarean is scheduled (vs spontaneous labor)
3. Assess if neuraxial anesthesia is planned
4. Apply appropriate discontinuation interval:
   • Prophylactic LMWH: 12-24 hours
   • Therapeutic LMWH: 24 hours
   • UFH: 4-6 hours
5. Document last dose timing clearly in medical record
6. Plan postpartum restart based on catheter removal and hemostasis

Quality of Evidence

The SMFM 2020 guidelines 2 provide the strongest framework for these recommendations (GRADE 1C for LMWH preference). Supporting research demonstrates safety of the 12-24 hour window for prophylactic LMWH 1 and identifies the critical 2-hour danger zone 5. The evidence specifically addresses obstetric populations, making it directly applicable to APS patients requiring cesarean delivery.

Key caveat: These recommendations assume prophylactic or intermediate dosing typical for APS thromboprophylaxis. Patients on full therapeutic anticoagulation for acute VTE require longer discontinuation intervals and potentially bridging strategies not covered by standard APS protocols.